GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSL:PHO) » Definitions » Price-to-Funds-From-Operations

PhotoCure ASA (OSL:PHO) Price-to-Funds-From-Operations : (As of Dec. 13, 2024)


View and export this data going back to 2000. Start your Free Trial

What is PhotoCure ASA Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


PhotoCure ASA Business Description

Industry
Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.